Skip to content

Effect of the combination use of ondansetron and metoclopramide on the incidence of nausea and vomiting in patients after orthognathic surgery

Effect of the combination use of ondansetron and metoclopramide on the incidence of nausea and vomiting in patients after orthognathic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118045
Enrollment
Unknown
Registered
2026-02-01
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deformitiesofteethandmandible, postoperative nausea and vomiting

Interventions

Ondansetron group (group A):Ondansetron (IV)
Ondansetron + Metoclopramide group (group B):Ondansetron + Metoclopramide (IV)

Sponsors

Beijing Stomatological Hospital , Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1.Ages 18-35, gender not restricted; 2.ASA GRADE I-II; 3.Cardiopulmonary function and other vital organ functions are essentially normal, and the patient can tolerate anesthesia and surgery;

Exclusion criteria

Exclusion criteria: 1.Obese patients with a BMI greater than 30; 2.Patients with apnea syndrome, suspected mask ventilation difficulty, and tracheal intubation difficulty; 3.Patients prone to nausea and vomiting due to motion sickness and vestibular dysfunction; 4.Patients with mental disorders such as depression and anxiety; 5.Patients with a history of epilepsy; 6.Patients with drug allergies to the medications used in the study protocol; 7.Pregnant and lactating women; 8.Patients with intellectual disabilities;

Design outcomes

Primary

MeasureTime frame
Incidence and severity of nausea and vomiting within 48 hours postoperatively;

Secondary

MeasureTime frame
Mean intraoperative arterial pressure of the patient;Numbers of trigeminal-vagal reflexes during surgery;Blood loss of the patient at the intraoperative period;Pain scores at 24 hours and 48 hours postoperative period;

Countries

China

Contacts

Public ContactLiu Yurui

Beijing Stomatological Hospital , Capital Medical University

1505681545@qq.com+86 10 57099162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026